Tag: KalVista

KalVista CEO Benjamin Palleiko sells shares value $74,363 By Investing.com

CAMBRIDGE, Mass.—KalVista Prescription drugs, Inc. (NASDAQ:), a $463 million market cap biopharmaceutical…

By Tycoon Herald 3 Min Read